{'52WeekChange': 0.057513952,
 'SandP52WeekChange': None,
 'address1': '26 Technology Drive',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 39.13,
 'askSize': 800,
 'averageDailyVolume10Day': 384212,
 'averageVolume': 655420,
 'averageVolume10days': 384212,
 'beta': None,
 'beta3Year': None,
 'bid': 39.13,
 'bidSize': 800,
 'bookValue': 4.998,
 'category': None,
 'circulatingSupply': None,
 'city': 'Irvine',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 39.78,
 'dayLow': 37.56,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -15.198,
 'enterpriseToRevenue': 31.296,
 'enterpriseValue': 1221757440,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '949 396 6321',
 'fiftyDayAverage': 38.158573,
 'fiftyTwoWeekHigh': 41.85,
 'fiftyTwoWeekLow': 15.25,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 24753557,
 'forwardEps': -1.13,
 'forwardPE': -34.62832,
 'fromCurrency': None,
 'fullTimeEmployees': 302,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.09899,
 'heldPercentInstitutions': 1.02756,
 'industry': 'Medical Devices',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/axonics.com',
 'longBusinessSummary': 'Axonics Modulation Technologies, Inc., a medical '
                        'technology company, engages in the development and '
                        'commercialization of sacral neuromodulation (SNM) '
                        'systems in the United States and internationally. The '
                        "company's SNM systems are used to treat patients with "
                        'overactive bladder, including urinary urge '
                        'incontinence and urinary urgency frequency, as well '
                        'as fecal incontinence, and non-obstructive urinary '
                        'retention. Its proprietary rechargeable SNM System '
                        '(r-SNM) delivers mild electrical pulses to the '
                        'targeted sacral nerve to restore normal communication '
                        'to and from the brain to reduce the symptoms of '
                        'bladder and bowel dysfunction. The company was '
                        'formerly known as American Restorative Medicine, Inc. '
                        'and changed its name to Axonics Modulation '
                        'Technologies, Inc. in August 2013. Axonics Modulation '
                        'Technologies, Inc. was incorporated in 2012 and is '
                        'based in Irvine, California.',
 'longName': 'Axonics Modulation Technologies, Inc.',
 'market': 'us_market',
 'marketCap': 1530726528,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_260926796',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -81434000,
 'nextFiscalYearEnd': 1640908800,
 'open': 39.46,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': 0.16,
 'phone': '949 396 6322',
 'previousClose': 39.9,
 'priceHint': 2,
 'priceToBook': 7.8291316,
 'priceToSalesTrailing12Months': 39.21019,
 'profitMargins': -2.08596,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 39.78,
 'regularMarketDayLow': 37.56,
 'regularMarketOpen': 39.46,
 'regularMarketPreviousClose': 39.9,
 'regularMarketPrice': 39.46,
 'regularMarketVolume': 323134,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 39119000,
 'sharesPercentSharesOut': 0.138,
 'sharesShort': 5396717,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 3984504,
 'shortName': 'Axonics Modulation Technologies',
 'shortPercentOfFloat': 0.1754,
 'shortRatio': 8.27,
 'startDate': None,
 'state': 'CA',
 'strikePrice': None,
 'symbol': 'AXNX',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -2.713,
 'twoHundredDayAverage': 33.086403,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': 'c5b6415e-1751-345c-b606-e09d4a4f7a7f',
 'volume': 323134,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.axonics.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '92618'}